Innovative Platform X-BODY Biosciences utilizes a cutting-edge DNA-tagged human antibody library to discover novel therapeutic targets, presenting opportunities for collaborations in advanced antibody development.
Early-stage Focus With revenue under one million and recent funding of 2.7 million dollars, the company is in an early growth phase, making it potentially receptive to strategic investments, partnerships, or pilot projects.
Niche Therapeutics Focusing on novel biotherapeutic compounds, X-BODY operates in a highly specialized segment, offering avenues to support research tools, assay development, or custom antibody solutions for targeted therapies.
Partnership Opportunities Given its small size and innovative approach, X-BODY may be interested in building collaborations with larger biotech firms or research institutions to accelerate drug discovery programs.
Market Potential Operating in a competitive landscape with similar small to mid-sized companies, X-BODY offers prospects for tailored solutions, licensing deals, or joint ventures to expand its product pipeline.
$10M$25M
$50M$100M
$10M$25M
$500M$1B
$10M$25M
$50M$100M
$10M$25M
$50M$100M
$10M$25M| X-BODY Biosciences Email Formats | Percentage |
| First.Last@x-bodybiosciences.com | 50% |
| FLast@x-bodybiosciences.com | 50% |
Biotechnology ResearchMassachusetts, United States2-10 Employees
X-BODY is a privately held biotechnology company focused on discovering novel biotherapeutic compounds. The company’s mission is to apply its innovative capabilities and remarkably diverse DNA-tagged human antibody library to the discovery of human antibodies against novel therapeutic targets.
Company Overview
Funding & FinancialsX-BODY Biosciences has raised a total of $2.7M of funding over 2 rounds. Their latest funding round was raised on Feb 12, 2013 in the amount of $2.7M.
X-BODY Biosciences's revenue is estimated to be in the range of $1M
Funding & FinancialsX-BODY Biosciences has raised a total of $2.7M of funding over 2 rounds. Their latest funding round was raised on Feb 12, 2013 in the amount of $2.7M.
X-BODY Biosciences's revenue is estimated to be in the range of $1M
1-888-653-2347 
support@leadiq.com